Analyst Ratings for Myriad Genetics Inc. (MYGN)

Updated: 2017-07-26

An average rating of Hold has been given to Myriad Genetics Inc. (NASDAQ:MYGN) by analysts covering the stock. MYGN had previously received a consensus rating of Hold a month ago.

15 analysts issued ratings on the stock, where 2 gave MYGN a buy rating, 0 issued an overweight rating, 9 gave a hold rating, 1 gave an underweight rating, and 3 gave a sell rating. Today, there are 0 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

A number of analysts gave price targets for MYGN. The most optimistic price target was 30, implying potential capital gains of 26.37 percent. The minimum price target given was 16, which equates to a potential downside of -32.6 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -1.65 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of 3.56 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts made negative revisions. Also over the last month, 2 analysts increased their estimates for the FY earnings, while 0 analysts decreased their estimates.

MYGN has an estimated earnings growth rate of 135.64 percent as forecasted by analysts. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. A lower PEG ratio is favorable, because people typically see that as an indicator of higher growth relative to stock price. Many investors consider PEG ratios between 0 and 1 as preferrable, even though it may be more relevant to compare the ratio to that of a firm's competitors. MYGN has a PEG ratio of 0.39.

In the trailing 52-weeks, MYGN hit 32.54 at the highest peak, while it's lowest trading point was 15.15. Today's price is 56.7 percent above the 52-week low, and 27.04 percent lower than its 52-week high. MYGN has a P/E ratio of 52.76. Investors typically compare the P/E ratio to a company's peers in the industry. The MYGN value stock report compares MYGN to some of its peers using value stock charts. The stock has a market capitalization of $1.63 billion. MYGN will post this quarters earnings in days, on 0000-00-00.